NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Nike shares target cut by Barclays, cites macroeconomic challenges

EditorEmilio Ghigini
Published 20/06/2024, 08:40 pm
© Reuters.
NKE
-

On Thursday, Barclays (LON:BARC) adjusted its stance on Nike (NYSE:NKE) shares, reducing the price target to $109.00 from the previous $114.00. The firm maintained its Overweight rating on the stock. The adjustment follows observations that Nike's North America Direct-to-Consumer (DTC) operations could face challenges due to several factors.

The report pointed out that the revised outlook is partly due to a weaker macroeconomic environment observed since the last quarter when Nike provided its fiscal year 2025 outlook. Additionally, the process of "franchise lifecycle management" is expected to pressure margins.

Further findings from the firm's checks during the quarter indicated a shift in sales of high-demand products. There has been a noticeable movement of these sales to sporting goods partner stores away from Nike's DTC channels.

The analysis also highlighted that data suggests a slowdown in the China market, which could potentially impact Nike's performance. The region has been a significant contributor to Nike's growth, and any deceleration in this market is closely monitored by investors.

Barclays' revised price target reflects the anticipated headwinds Nike may face, while the Overweight rating indicates a belief that the stock still holds potential for investors despite the near-term concerns.

In other recent news, Nike Inc (NYSE:NKE). has been the focus of several financial revisions and strategic shifts. Truist Securities maintained its hold rating on Nike shares with a price target of $99, anticipating consistent performance in line with their fourth-quarter estimates.

UBS reaffirmed its Buy rating on Nike's stock with a price target of $125, despite concerns about Nike's sales growth. Evercore ISI reduced its price target for Nike to $110, citing a challenging environment and potential order cancellations for Fall 2024.

Morgan Stanley (NYSE:MS) also lowered its price target to $114 due to concerns about Nike's Q1 guidance. Deutsche Bank (ETR:DBKGn) set a price target of $115, emphasizing Nike's innovation strategy, while Wells Fargo (NYSE:WFC) revised its price target down to $115 due to concerns about Nike's direct-to-consumer sales and supplier issues.

In terms of recent company news, Nike announced a quarterly cash dividend of $0.37 per share and launched a significant innovation in athletic footwear with its first sculpted, visible Air Zoom (NASDAQ:ZM) unit in the Pegasus Premium running shoe.

The company is also initiating workforce reductions as part of widespread cost-saving measures. These developments provide investors with a recent snapshot of the financial landscape surrounding Nike Inc.

InvestingPro Insights

Amid the challenges faced by Nike, including the anticipated margin pressures and shifting sales dynamics, the company's financial health remains robust. As per the latest data, Nike's market capitalization stands at a sturdy $143.06 billion, with a P/E ratio of 27.58, reflecting investor confidence in its earnings capacity. Moreover, the company's gross profit margin for the last twelve months as of Q3 2024 is a solid 44.3%, showcasing its ability to maintain profitability despite macroeconomic headwinds.

An InvestingPro Tip highlights Nike's resilience, noting that the company has raised its dividend for 22 consecutive years, signaling a commitment to shareholder returns. Additionally, it's worth mentioning that Nike operates with a moderate level of debt, which provides financial flexibility and stability.

For investors seeking a deeper analysis, there are 11 additional InvestingPro Tips available, offering insights into Nike's financial performance and market position. To explore these further, visit https://www.investing.com/pro/NKE and remember to use the coupon code PRONEWS24 for an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.